Aptuit is a global pharmaceutical services company that delivers early to mid-phase drug development solutions to more than 800 companies by applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry. From seven locations around the world, including our strategic partner in India, Aptuit assists clients by shortening their timelines, accelerating their portfolio to the next milestones and delivering on time, in full. We solve scientific problems through technical expertise and superior project management. We provide significant value to our clients by delivering high quality services that exceed regulatory compliance standards.
Aptuit is partnered with Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors.
For more information about the offerings of our business lines, click the “Services” tab above. To learn more about Aptuit, visit www.aptuit.com.
Aptuit: engineering a better drug development process through scientific excellence
Specialties
Drug Design & Discovery, Preclinical Biosciences, API Development and Manufacture, Solid State Chemistry, Solid, Oral and Sterile Dosage Form Development and Manufacture, Clinical Sciences, Consulting, Aptuit INDiGO® (Accelerated Drug Development Program)
New hires at Aptuit
Aptuit Activity on LinkedIn
-
Aptuit has a new Lead Generation Specialist-III
Yogesh Datar is now Lead Generation Specialist-III, was SCIENTIST at Aptuit
-
Aptuit has a new Scientist (Oncology)
Antonietta Silini is now Scientist (Oncology), was Scientific writer at Fondazione Poliambulanza Istituto Ospedaliero
